Tse Justin R, Felker Ely R, Tse Gary, Liang Tie, Shen Jody, Kamaya Aya
Department of Radiology, Stanford University School of Medicine, Stanford, California.
Department of Radiological Sciences, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, California.
J Am Coll Radiol. 2022 Apr;19(4):513-520. doi: 10.1016/j.jacr.2022.01.010. Epub 2022 Feb 28.
The aim of this study was to compare catheter angiography (CA) and colonoscopy outcomes after successful CT angiographic (CTA) localization for patients with overt lower gastrointestinal bleeding (LGIB).
Seventy-one consecutive patients from two institutions between 2010 and 2020 had both contrast extravasation on CTA imaging in the lower gastrointestinal tract and subsequent CA or colonoscopy. The primary outcome was confirmation of active bleeding during CA or colonoscopy (defined as confirmation yield). The secondary outcomes were to determine therapeutic yield (hemostatic therapy), time to procedure, rebleeding rate, and adverse outcome rates (defined as surgery, acute kidney injury, initiation of dialysis, and overall mortality). Univariate analyses and multivariable analyses with P < .05 were used to determine statistical significance.
Forty-four patients underwent CA and 27 underwent colonoscopy. CA had higher overall confirmation yield (55% vs 26%, P = .026), whereas therapeutic yields were similar (70% vs 56%, P = .214). Time to procedure was 5.1 ± 3.4 hours for CA and 15.5 ± 13.6 hours for colonoscopy (P < .001). On multivariable analysis, shorter time to procedure was the only statistically significant predictor of confirmation yield (P = .037) and therapeutic yield (P = .013), whereas procedure, hemoglobin, transfusions, and hemodynamic instability were not. Adverse events and rebleeding were not statistically different between patients who underwent CA and colonoscopy (P > .05).
Shorter time to procedure was the only statistically significant predictor of confirmation and therapeutic yield after CTA localization of LGIB. Because CA can be performed sooner than colonoscopy without increased rates of adverse outcomes or rebleeding, CA may be a reasonable first-line treatment option in patients with CTA localization of LGIB.
本研究旨在比较显性下消化道出血(LGIB)患者在成功进行CT血管造影(CTA)定位后,导管血管造影(CA)和结肠镜检查的结果。
2010年至2020年间,来自两家机构的71例连续患者在CTA成像中均显示下消化道有造影剂外渗,随后接受了CA或结肠镜检查。主要结局是在CA或结肠镜检查期间确认活动性出血(定义为确认率)。次要结局是确定治疗率(止血治疗)、手术时间、再出血率和不良结局发生率(定义为手术、急性肾损伤、开始透析和全因死亡率)。采用单因素分析和P<0.05的多因素分析来确定统计学意义。
44例患者接受了CA检查,27例接受了结肠镜检查。CA的总体确认率更高(55%对26%,P = 0.026),而治疗率相似(70%对56%,P = 0.214)。CA的手术时间为5.1±3.4小时,结肠镜检查为15.5±13.6小时(P<0.001)。在多因素分析中,较短的手术时间是确认率(P = 0.037)和治疗率(P = 0.013)的唯一具有统计学意义的预测因素,而检查方法、血红蛋白、输血和血流动力学不稳定则不是。接受CA和结肠镜检查的患者之间不良事件和再出血在统计学上无差异(P>0.05)。
较短的手术时间是LGIB患者CTA定位后确认率和治疗率的唯一具有统计学意义的预测因素。由于CA可以比结肠镜检查更快地进行,且不良结局或再出血率没有增加,因此CA可能是LGIB患者CTA定位后的合理一线治疗选择。